The voice of the patient during clinical trials must be captured, to fully record the impact of treatment toxicity and symptoms.
Janice Withycombe, PhD, MN, CCRP
Advertisement
Articles by Janice Withycombe, PhD, MN, CCRP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Frontline Sevabertinib for HER2-Mutant Advanced NSCLC Patients
2
FDA Grants Final Approval to Cabozantinib Capsules Across Multiple Solid Tumor Indications
3
Advocacy and Self-Care: Emily Beard on Oncology Navigation
4
Frontline Sevabertinib Approved in HER2-Mutant NSCLC: Nursing Priorities
5